Steven Prestrelski

Insider Reports History

Entity
Individual
Location
C/O Xeris Pharmaceuticals, 180 N. Lasalle Street, Suite 1800, Chicago, IL
Signature
/s/ Beth Hecht, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steven Prestrelski:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xeris Biopharma Holdings, Inc. Chief Scientific Officer Common Stock 720K $1.35M $1.87 Jan 31, 2023 Direct
XERIS PHARMACEUTICALS INC Chief Scientific Officer Common Stock 0 Oct 5, 2021 Direct
XERIS PHARMACEUTICALS INC Chief Scientific Officer Stock Option (Right to Buy) 0 Oct 5, 2021 Direct

Insider Reports Filed by Steven Prestrelski

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XERS Xeris Biopharma Holdings, Inc. Jan 31, 2023 1 $0 4 Feb 1, 2023 Chief Scientific Officer
XERS Xeris Biopharma Holdings, Inc. Feb 22, 2022 3 -$19.4K 4 Feb 24, 2022 Chief Scientific Officer
XERS Xeris Biopharma Holdings, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Chief Scientific Officer
XERS Xeris Biopharma Holdings, Inc. Oct 5, 2021 8 $0 4 Oct 5, 2021 Chief Scientific Officer
XERS XERIS PHARMACEUTICALS INC Oct 5, 2021 8 $0 4 Oct 5, 2021 Chief Scientific Officer
XERS Xeris Biopharma Holdings, Inc. Oct 5, 2021 0 $0 3 Oct 5, 2021 Chief Scientific Officer